QUIDEL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-20: Reporting owner SCHULER JACK W; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-20: Reporting owner SCHULER JACK W; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-20: Reporting owner SCHULER JACK W; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-20: Reporting owner SCHULER JACK W; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,331 0 owned after | $9.93 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,331 0 owned after | $13.97 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,154 0 owned after | $16.25 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,002 0 owned after | $11.96 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,449 0 owned after | $13.25 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,800 0 owned after | $14.43 exercise price | 2013-12-24 | |
| 2013-12-20 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,800 0 owned after | $15.73 exercise price | 2013-12-24 | |
| 2013-10-29 | PULIDO MARK Director | 4 | Non-Qual Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,750 0 owned after | $5.44 exercise price | 2013-10-31 | |
| 2013-05-29 | Bujarski Robert Joseph Officer (SVP, Bus Dev & Gen Counsel) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,808 0 owned after | $8.50 exercise price | 2013-05-30 | |
| 2013-05-28 | Bujarski Robert Joseph Officer (SVP, Bus Dev & Gen Counsel) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,000 6,808 owned after | $8.50 exercise price | 2013-05-30 | |
| 2013-05-17 | Bujarski Robert Joseph Officer (SVP, Bus Dev & Gen Counsel) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,196 28,808 owned after | $8.50 exercise price | 2013-05-17 | |
| 2013-05-15 | Bujarski Robert Joseph Officer (SVP, Bus Dev & Gen Counsel) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,283 48,004 owned after | $8.50 exercise price | 2013-05-17 | |
| 2013-05-14 | SCHULER JACK W Director, 10% Owner | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,081 8,081 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-05-14 | PULIDO MARK Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,607 10,607 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-05-14 | POLAN MARY LAKE PH D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,081 8,081 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-05-14 | Dammeyer Rodney F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,081 8,081 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-05-14 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,081 8,081 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-05-14 | Brown Thomas D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,081 8,081 owned after | $23.70 exercise price | 2013-05-16 | |
| 2013-02-28 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,719 0 owned after | $7.50 exercise price | 2013-03-01 | |
| 2013-02-28 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,133 51,401 owned after | $8.50 exercise price | 2013-03-01 | |
| 2013-02-25 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,736 19,736 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | STEWARD RANDALL J Officer (Chief Financial Officer) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,473 39,473 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | Stenzel Timothy Todd Officer (Chief Science Officer) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,671 24,671 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | SMITS MARK W Officer (SVP-Commercial Operations) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,539 34,539 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | Bujarski Robert Joseph Officer (SVP, General Counsel & Secy) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,605 29,605 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4/A | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,217 94,217 owned after | $22.21 exercise price | 2013-03-27 | |
| 2013-02-25 | TAMERIUS JOHN Officer (SVP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,938 18,938 owned after | $22.21 exercise price | 2013-02-27 | |
| 2013-02-25 | STEWARD RANDALL J Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,877 37,877 owned after | $22.21 exercise price | 2013-02-27 | |
| 2013-02-25 | Stenzel Timothy Todd Officer (Chief Science Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,673 23,673 owned after | $22.21 exercise price | 2013-02-27 | |
| 2013-02-25 | SMITS MARK W Officer (SVP-Commercial Operations) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,142 33,142 owned after | $22.21 exercise price | 2013-02-27 | |
| 2013-02-25 | Bujarski Robert Joseph Officer (SVP, General Counsel & Secy) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,408 28,408 owned after | $22.21 exercise price | 2013-02-27 | |
| 2013-02-25 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +92,326 92,326 owned after | $22.21 exercise price | 2013-02-27 |